SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 and Rule 13a-17
or 15d-17 thereunder
BIO-TECHNOLOGY GENERAL CORP.
----------------------------------------------
(Exact name of issuer as specified in charter)
70 Wood Avenue South, Iselin, New Jersey 08830
----------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (908) 632-8800
I. CHANGE IN NUMBER OF WARRANTS OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of security: Warrants to purchase Common Stock at an exercise
price of $5.49 per share (the "L Warrants").
2. Number of L Warrants outstanding before the change: 6,206,250 (at
December 28, 1995)
3. Number of L Warrants outstanding after the change: 3,536,250
4. Effective date of change: December 29, 1995
5. Method of change: Specify method (such as merger, acquisition, exchange,
distribution, stock split, reverse split, acquisition of stock for
treasury, etc.)
Acquisition by issuer and subsequent cancellation.
<PAGE>
Give brief description of transaction: On December 29, 1995 the issuer
received 2,670,000 L Warrants from an entity in consideration for partial
satisfaction of amounts owed to the issuer from such entity. The issuer
cancelled the purchased L Warrants at that time.
II. CHANGE IN NAME OF ISSUER
1. Name prior to change_________________________________________________________
2. Name after change____________________________________________________________
3. Effective date of charter amendment changing name____________________________
4. Effective date of charter amendment changing name____________________________
5. Date of shareholder approval of change, if required__________________________
Date: March ___, 1996 -------------------------------------
Sim Fass
President and Chief Executive Officer
2
